What is Curis Inc?
, a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed/refractory primary central nervous system lymphoma. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.06M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.